跳至主要内容
临床试验/NCT00190645
NCT00190645已完成3 期

Long-Term Monitoring of Safety in Subjects Treated With Duloxetine for Stress Urinary Incontinence

Eli Lilly and Company4 个研究点 分布在 2 个国家目标入组 600 人开始时间: 2001年2月最近更新:
适应症
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
600
试验地点
4
主要终点
To generate long-term safety data for duloxetine in the treatment of women with stress urinary incontinence(SUI).

研究概览

简要总结

The patients are being followed in this study to determine the safety of taking the medication Duloxetine for a long period of time. The patients participating in this study suffer from Stress Urinary Incontinence.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Successfully completed the protocol for Study F1J-MC-SBAV.

排除标准

  • Treatment with a drug, not including study medication, that has not received regulatory approval at the time of study entry.
  • Use of excluded medications within 14 days prior to study entry or at any time during the study.

结局指标

主要结局

To generate long-term safety data for duloxetine in the treatment of women with stress urinary incontinence(SUI).

次要结局

  • To collect data to demonstrate the maintenance of effect of duloxetine as measured by Patient Global Impression of Improvement (PGI-I) questionnaire.

研究者

申办方类型
Industry

研究点 (4)

Loading locations...

相似试验